Cover Image
市場調查報告書

印度的IVD (體外診斷) 市場

IVD in India

出版商 Kalorama Information 商品編碼 350719
出版日期 內容資訊 英文 240 Pages
訂單完成後即時交付
價格
Back to Top
印度的IVD (體外診斷) 市場 IVD in India
出版日期: 2016年01月06日 內容資訊: 英文 240 Pages
簡介

本報告提供印度的IVD (體外診斷) 市場展望調查,印度的經濟、社會背景,人口動態和患者人口,印度的IVD市場SWOT分析,影響市場成長因素分析,各用途的銷售額規模的變化與預測,國內外的主要企業簡介等彙整。

第1章 摘要整理

  • 簡介
  • 調查範圍、手法
  • 主要調查結果
  • 印度的市場背景
  • 課題
  • 疾病的擴大要素
  • 感染疾病的威脅
  • 印度經濟
  • 金磚四國的IVD市場
  • 印度的IVD市場
  • SWOT分析
  • 主要企業

第2章 新興國家的醫療、診斷:印度市場

  • 背景
  • 人口動態、患者人口
  • 肥胖症
    • 疾病趨勢
  • 糖尿病
  • 癌症
  • 過敏、氣喘
  • 心臟血管疾病
  • 新的病毒、疾病
  • 抗生素抗性
  • 臨床實驗室檢驗
  • 檢驗的各種類型
  • 檢驗地方
  • 市場機會:各種類
  • 照護現場 (POC) 檢驗
  • 核心實驗室檢驗
  • 分子化驗
  • 血液檢驗
  • 血液凝固檢驗
  • 微生物學
  • 在血庫的檢驗
  • 組織學、細胞學
  • 印度的經濟發展的今後
  • 生活水準的上升
  • 年輕會說英語的人力資源
  • 貪污、賄賂
  • 金磚四國標準:印度的IVD市場
  • 對象市場:金磚四國的城市人口
  • 醫療費:政府的支出
  • 金磚四國的醫療部門的能力
  • IVD支出額

第3章 印度的IVD市場:SWOT分析

第4章 市場規模

  • 簡介
  • 市場
  • 整體市場
  • 免疫測量
  • 臨床化學
  • 血液檢驗
  • 照護現場/OTC
  • 分子檢驗
  • 尿液檢查
  • 其他IVD檢驗

第5章 產業及企業間的配合措施

  • 簡介
  • 印度的市場領導
  • 印度的IVD經營者
  • 國際IVD企業:最近的配合措施
    • Abbott Laboratories
    • Affymetrix, Inc.
    • Alere
    • Arkray
    • Beckman Coulter, Inc./Danaher
    • Becton, Dickinson & Co
    • Biohit Oy
    • bioMerieux, Inc.
    • Bio-RAD Laboratories, Inc.
    • Daan Gene Co., Ltd.
    • Danaher Corp.
    • Gen-Probe, Inc.
    • Grifols
    • Hologic, Inc.
    • Horiba Medical
    • Instrumentation Laboratory
    • Laboratory Corporation of America
    • Luminex Corporation
    • MedMira
    • Mindray Medical International, Ltd.
    • Myriad Genetics
    • Ortho Clinical Diagnostics
    • PerkinElmer
    • Promega Corporation
    • QIAGEN N.V.
    • Quest Diagnostics
    • Radiometer A/S
    • Roche
    • Shanghai Fosun Pharmaceutical Co. Ltd.
    • Shanghai Kehua Bio-engineering
    • Siemens
    • SRL Diagnostics
    • Sysmex Corp.
    • Thermo Fisher Scientific

圖表

目錄
Product Code: KLI5819260

With a population of more than 1 billion, India is the world's second largest country and therefore also a significant potential market for goods and services. India has the world's seventh-largest economy by nominal GDP and third largest by purchasing power parity. The country is one of the G-20 major economies with approximately 7% average growth rate for the last two decades. In the final quarter of 2014, India became the world's fastest growing major economy, replacing China.

As an in vitro diagnostics (IVD) market, India leads the emerging nations and follows only the populous, developed economy markets of the United States, western European countries, Japan and China. The country and its healthcare system are confronted by challenges shared by the developing countries, as well as rising rates of diabetes, cardiovascular disease, and the diseases of aging.

IVD in India places India and its IVD market in context with the developing world in terms of diseases, economic and healthcare system development, and other key metrics related to health expenditures and diagnostics. India as an IVD market opportunity is defined by its standing next to other populous countries with demonstrated economic promise for over the past decade - Brazil, Russia and China.

The report presents current analysis of the Indian IVD industry and provides forecasts to 2025. The report takes an in-depth look at the market, providing data on the size and growth of the total Indian market as well as on the following IVD in India market segments:

  • Immunoassays
  • Clinical Chemistry
  • Hematology
  • Point of Care/OTC
  • Molecular
  • Urinalysis
  • Other IVD Tests

IVD in India features a ten year forecast period, with projections of the total Indian IVD market and its component segments from 2015-2025, including:

  • Total IVD Sales in India, 2015-2025
  • IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2015
  • IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2020
  • IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2025

The report presents the main issues and trends affecting this market, influencing its move into the future. Some of these include:

  • The Future of Indian Economic Growth
  • Market Segment Opportunities
  • BRIC Metrics - Indian IVD Market in Context
  • IVD Spending
  • Strengths - Conditions That Support Market Growth
  • Weaknesses - Factors That Pose Barriers to Market Success and Entry
  • Opportunities - Rural Healthcare and Technology Partnerships
  • Threats - Domestic and Chinese Competition

The report provides detailed information regarding the IVD industry and company activity in India, noting market leaders and the recent activity of Indian IVD players and international IVD companies in India. Companies discussed include:

  • Abbott Laboratories
  • Affymetrix, Inc.
  • Alere
  • Arkray
  • Beckman Coulter, Inc./Danaher
  • Becton, Dickinson & Co.
  • Biohit Oy
  • bioMérieux, Inc.
  • Bio-RAD Laboratories, Inc.
  • Daan Gene Co., Ltd.
  • Danaher Corp.
  • Gen-Probe, Inc.
  • Grifols
  • Hologic, Inc.
  • Horiba Medical
  • Instrumentation Laboratory
  • Laboratory Corporation of America
  • Luminex Corporation
  • MedMira
  • Mindray Medical International, Ltd.
  • Myriad Genetics
  • Ortho Clinical Diagnostics
  • PerkinElmer
  • Promega Corporation
  • QIAGEN N.V.
  • Quest Diagnostics
  • Radiometer A/S
  • Roche
  • Shanghai Fosun Pharmaceutical Co. Ltd.
  • Shanghai Kehua Bio-engineering
  • Siemens
  • SRL Diagnostics
  • Sysmex Corp.
  • Thermo Fisher Scientific

Information for this report was gathered from a wide variety of published sources including company reports, catalogs, materials and public filings; government documents; trade journals; newspapers and business press; analysts' reports and other sources. Interviews with industry experts were conducted to capture the perspectives from market participants' point of view and assess trends, and form the basis of the forecasting and competitive analysis. Sales estimates are provided for the 2015 base year and forecasts are provided through 2025. The size of each market segment refers to manufacturers' revenues in U.S. dollars.

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Introduction
  • Scope and Methodology
  • Major Findings of the Report
  • India in Context - A Rapidly Developing Economy with Major Demographic
  • Challenges
  • Demographic Aging
  • Disease Drivers
  • Infectious Disease Threats
  • Indian Economy
  • IVD Market in the BRIC Countries
  • IVD Market in India
  • SWOT Analysis
  • Leading Players

TWO: INTRODUCTION TO HEALTH CARE AND DIAGNOSTICS IN THE DEVELOPING WORLD - INDIA IN CONTEXT

  • Background
  • Population Trends and Disease Demographics
  • Obesity
  • Disease Trends
  • Diabetes
  • Cancer
  • Allergy and Asthma
  • Cardiovascular Disease
  • Emerging Viruses and Diseases
  • Antimicrobial Drug Resistance
  • Clinical Lab Tests
  • Types of Tests
  • Venues for Test Usage
  • Market Segment Opportunities
  • Point-of-Care (POC) Testing
  • Core Lab Tests
  • Molecular Assays
  • Hematology
  • Coagulation
  • Microbiology
  • Tests Used in Blood Banking
  • Histology and Cytology
  • The Future of Indian Economic Growth
  • Rising Standards of Living
  • Young, English-Speaking Labor Force
  • Corruption and Bribery
  • Exchange Rate
  • BRIC Metrics - Indian IVD Market in Context
  • Available Markets - Urban Populations in BRIC Countries
  • Paying for Healthcare - Government Expenditures and the Culture of Spending
  • Healthcare Capacities in BRIC Nations - A Work in Progress
  • IVD Spending

THREE: INDIA IVD SWOT ANALYSIS

  • Introduction
  • Strengths - Conditions That Support Market Growth
  • Government Support of the Emerging Indian Healthcare Market
  • Expanding Medical Education
  • Increasing Health Insurance Penetration
  • Improving Intellectual Property Protection
  • Thriving Biotech Industry
  • Contract Research and High Technology
  • Returning Scientists
  • Growing Hospital Sector
  • Expanding Clinical Labs
  • Medical Tourism
  • Strong IT Sector
  • Weaknesses - Factors That Pose Barriers to Market Success and Entry
  • Traditional Medicine
  • Resource Constraints in Hospitals
  • Culture and Business Environment
  • Quality and Safety Concerns
  • Lack of Medical Device and Diagnostics Regulation
  • Lack of IVD R&D
  • High Out of Pocket Consumer Expenditures
  • Healthcare Pricing
  • Opportunities - Rural Healthcare and Technology Partnerships
  • Threats - Domestic and Chinese Competition
  • Domestic Competition
  • Chinese Competition

FOUR: INDIA IVD MARKET SIZE

  • Introduction
  • The Market
  • Total Indian IVD Market
  • Immunoassays
  • Clinical Chemistry
  • Hematology
  • Point of Care/OTC
  • Molecular
  • Urinalysis
  • Other IVD Tests

FIVE: INDUSTRY AND COMPANY ACTIVITY IN INDIA

  • Introduction
  • Market Leaders in India
  • Indian IVD Players
  • International IVD Companies - Recent Activity
  • Abbott Laboratories
  • Affymetrix, Inc.
  • Alere
  • Arkray
  • Beckman Coulter, Inc./Danaher
  • Becton, Dickinson & Co
  • Biohit Oy
  • bioMérieux, Inc.
  • Bio-RAD Laboratories, Inc.
  • Daan Gene Co., Ltd.
  • Danaher Corp.
  • Gen-Probe, Inc.
  • Grifols
  • Hologic, Inc.
  • Horiba Medical
  • Instrumentation Laboratory
  • Laboratory Corporation of America
  • Luminex Corporation
  • MedMira
  • Mindray Medical International, Ltd.
  • Myriad Genetics
  • Ortho Clinical Diagnostics
  • PerkinElmer
  • Promega Corporation
  • QIAGEN N.V.
  • Quest Diagnostics
  • Radiometer A/S
  • Roche
  • Shanghai Fosun Pharmaceutical Co. Ltd.
  • Shanghai Kehua Bio-engineering
  • Siemens
  • SRL Diagnostics
  • Sysmex Corp.
  • Thermo Fisher Scientific

LIST OF EXHIBITS

ONE: EXECUTIVE SUMMARY

  • Exhibit 1-1: Global Map of India
  • Table 1-1: BRIC IVD Markets by Country, 2015 - 2020
  • Table 1-2: IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2015
  • Table 1-3: Indian IVD Growth Rates of Market Segments (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other), 2015-2020,2015-2025 and 2020-2025
  • Exhibit 1-2: IVD Market Share in India by Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2015, 2020 and 2025
  • Exhibit 1-3: IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2015, 2020 and 2025
  • Exhibit 1-4: Indian Life Expectancy by State, 2014

TWO: INTRODUCTION TO HEALTH CARE AND DIAGNOSTICS IN THE DEVELOPING WORLD - INDIA IN CONTEXT

  • Table 2-1: Elderly Support Ratio in India, Other BRIC and Selected Countries(2010/2050) (Niger, Uganda, Pakistan, India, Egypt, Guatemala, Morocco, Mexico,Brazil, China, Russia, United States, France, Japan, World)
  • Table 2-2: Selected Worldwide Disease Statistics, 2015 (Respiratory Infections,Malaria, HIV/AIDS, Chlamydia, Gonorrhea, Maternal Conditions, Asthma,Cardiac Disease, Diabetes, Cancer, Syphilis, Tuberculosis, Hepatitis)
  • Exhibit 2-1: Diabetes Population by Country, 2015
  • Exhibit 2-2: Cardiovascular Disease Death as a Percentage of Total Deaths, 2015
  • Table 2-3: Types of IVD and Clinical Laboratory Tests, 2015
  • Table 2-4: Clinical Lab Counts and Lab Automation Penetration in BRIC Countries
  • Exhibit 2-3: Countries by Nominal per Capita GDP in 2014
  • Exhibit 2-4: Per Capita GDP by Indian Province in 2014
  • Exhibit 2-5: Linguistic Map of India
  • Table 2-5: Available (Urban) Market Development in BRIC Countries(2003/2015)
  • Table 2-6: Government and Total Health Expenditures in BRIC and Comparison Countries, 2013 (United States, France, Germany, Italy, Japan, United Kingdom,Australia, Brazil, South Africa, Argentina, South Korea, Vietnam, Poland,Turkey, Mexico, Russia, Nigeria, China, Thailand, India, Indonesia)
  • Table 2-7: Growth Rates of Government and Total Healthcare Expenditures and Real GDP (BRIC and Comparison Countries; 2003-2013) (India, Nigeria,Argentina, Vietnam, Indonesia, Turkey, Russia, Poland, Thailand, Brazil, South Korea, South Africa, Australia, Mexico, United States, Germany, United Kingdom, France, Japan, Italy)
  • Table 2-8: Healthcare System Capacities - BRIC and Comparison Countries (Argentina, Australia, Brazil, China, France, Germany, India, Indonesia, Italy, Japan, South Korea, Mexico, Nigeria, Poland, Russia, South Africa, Thailand,Turkey, United Kingdom, United States, Vietnam)
  • Table 2-9: Per Capita IVD Expenditures and IVD Markets by Country, 2015(United States, Japan, Germany, France, Italy, China, Spain, United Kingdom,Brazil, Russia, India)
  • Table 2-10: BRIC IVD Markets by Country, 2015 - 2020 ($ millions)

THREE: INDIA IVD SWOT ANALYSIS

  • Table 3-1: Cost Savings from Medical Tourism for Various Procedures, 2015(Rhinoplasty, Face-Lift, Breast Augmentation, Breast Reduction, Complete Liposuction, Gluteal Augmentation)
  • Exhibit 3-1: Ayurvedic Medicine Doshas
  • Exhibit 3-2: Ayurvedic Medicine vs. Western Medicine
  • Exhibit 3-3: Common Homeopathic Remedies
  • Table 3-2: Out-Of-Pocket, Other Private and Government Healthcare Expenditures in BRIC and Comparison Countries (% of Total Expenditures) (South Africa,France, United Kingdom, United States, Germany, Thailand, Turkey, Japan,Australia, Italy, Poland, Argentina, Brazil, South Korea, China, Russia, Mexico,Indonesia, Vietnam, India, Nigeria)
  • Table 3-3: Chinese IVD Companies

FOUR: INDIA IVD MARKET SIZE

  • Exhibit 4-1: Global IVD and Clinical Lab Market, 2015 (India, Russia, Brazil,United Kingdom, Spain, China, Italy, France, Germany, Japan, United States)
  • Exhibit 4-2: Global IVD and Clinical Lab Market, 2020 (India, Russia, Brazil,United Kingdom, Spain, China, Italy, France, Germany, Japan, United States)
  • Exhibit 4-3: Global IVD and Clinical Lab Market, 2025 (India, Russia, Brazil,United Kingdom, Spain, China, Italy, France, Germany, Japan, United States)
  • Table 4-1: Total IVD Sales in India, 2015-2025
  • Exhibit 4-4: Total IVD Sales in India, 2015-2025
  • Table 4-2: IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2015
  • Exhibit 4-5: IVD Sales in China by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2015
  • Table 4-3: IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2020
  • Exhibit 4-6: IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2020
  • Table 4-4: IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2025
  • Exhibit 4-7: IVD Sales in India by Market Segment (Immunoassays, Clinical Chemistry, Hematology, POC/OTC, Molecular, Urinalysis, Other) in 2025
  • Table 4-5: Immunoassay Sales in India, 2015-2025
  • Exhibit 4-8: Immunoassay Sales in India, 2015-2025
  • Table 4-6: Clinical Chemistry Sales in India, 2015-2025
  • Exhibit 4-9: Clinical Chemistry Sales in India, 2015-2025
  • Table 4-7: Hematology Sales in India, 2015-2025
  • Exhibit 4-10: Hematology Sales in India, 2015-2025
  • Table 4-8: Point of Care/OTC Sales in India, 2015-2025
  • Exhibit 4-11: Point of Care/OTC Sales in India, 2015-2025
  • Table 4-9: Molecular Test Sales in India, 2015-2025
  • Exhibit 4-12: Molecular Test Sales in India, 2015-2025
  • Table 4-10: Urinalysis Test Sales in India, 2015-2025
  • Exhibit 4-13: Urinalysis Test Sales in India, 2015-2025
  • Exhibit 4-14: uChek Urinalysis Test
  • Table 4-11: Other IVD Test Sales in India, 2015-2025
  • Exhibit 4-15: Other IVD Test Sales in India, 2015-2025

FIVE: INDUSTRY AND COMPANY ACTIVITY IN INDIA

  • Table 5-1: Leading Global IVD Companies in India
  • Table 5-2: Selected Domestic IVD Companies in India
Back to Top